Effectiveness of Tunneled Pleural Catheter Placement in Patients with Malignant Pleural Effusions

ABSTRACT

Pleural effusions (PE) occur frequently among patients with various types of advanced malignancies, resulting in remarkably decreased quality of life. Treatment of malignant PE includes placement of a chest tube with subsequent placement of a tunneled pleural catheter. We reviewed our experience with tunneled pleural catheter use to assess outcomes and resource utilization of this intervention. A retrospective study of consecutive patients (n = 163, including 41 outpatients) who were treated between July 2001 and April 2008 with tunneled pleural catheters was performed to evaluate operative and discharge outcomes. The average age of the patients was 59.32 years (range: 24 to 89). Lung cancer, breast cancer, and ovarian cancer were common primary diseases in this patient population. The mean hospital stay after tunneled pleural catheter placement was 3.19 days (range: 0 to 56), with 41 patients treated as outpatients. Thirteen inpatient deaths were related to the patients' primary diseases, but no deaths were due to drain placement itself. Eight patients (4.91%) required reoperation to replace a nonfunctioning drain or to add an additional drain, and six patients underwent a second procedure to place a contralateral drain. One hundred twenty-six patients (77.30%) were discharged home following the procedure and hospital stay. Fifty-five people achieved spontaneous pleurodesis. Tunneled pleural catheter placement is a safe and effective approach to the treatment of PE. The advantages of tunneled pleural catheter placement include symptomatic relief and improved quality of life. This method allows patients to spend time at home with their family and avoid prolonged hospitalization.

KEYWORDS

Tunneled pleural catheter - malignant pleural effusions

REFERENCES

• 1 Yataco J C, Dweik R A. Pleural effusions: evaluation and management.  Cleve Clin J Med. 2005;  72 854-856, 858, 862–864 passim
• 2 Denver Biomedical. Pleurx catheter instructions for use. Golden, CO: Author;
• 3 Putnam Jr J B, Walsh G L, Swisher S G et al.. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.  Ann Thorac Surg. 2000;  69 369-375
• 4 Pollak J S. Malignant pleural effusions: treatment with tunneled long-term drainage catheters.  Curr Opin Pulm Med. 2002;  8 302-307
• 5 Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.  Chest. 2006;  129 362-368
• 6 Putnam Jr J B, Light R W, Rodriguez R M et al.. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions.  Cancer. 1999;  86 1992-1999
• 7 Ohm C, Park D, Vogen M et al.. Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of malignant pleural effusions.  Am Surg. 2003;  69 198-202 discussion 202
• 8 van den Toorn L M, Schaap E, Surmont V FM, Pouw E M, van der Rijt K CD, van Klaveren R J. Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter.  Lung Cancer. 2005;  50 123-127
• 9 Warren W. Talc pleurodesis for malignant pleural effusions is preferred over the Pleurx catheter (contrary position).  Ann Surg Oncol. 2007;  14 2700-2701
• 10 Pien G W, Gant M J, Washam C L, Sterman D H. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.  Chest. 2001;  119 1641-1646
• 11 Brubacher S, Gobel B H. Use of the Pleurx Pleural Catheter for the management of malignant pleural effusions.  Clin J Oncol Nurs. 2003;  7 35-38